Surna (SRNA) Announces Largest Contract in its History
One of the essential elements in the extracts vertical advancements is the adoption of good manufacturing practices. According to the World Health Organization website, “Good Manufacturing Practice (GMP) is that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use.”
Total revenues were $4,907,889 compared to $3,056,431 reported in the same quarter in 2019, representing an increase of over 61%, and a 29.8% increase over the first fiscal quarter of 2021. Gross margin increased to 55% - an increase of 7% over the quarter ended November 30, 2019.
PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment
Tauriga Sciences (TAUG) Completes Payment for the Entirety of its 3rd Production Run of its CBD Infused Gum Drop Product, Tauri-Gummies
Tauriga Sciences Inc. (TAUG) Completes Translated Version of its Tauri-Gum Packaging Language
ZA Group (ZAGG) Acquires Majority Stake In Econic Crop Solutions, Inc, a Manufacturer of Indoor Cannabis Products
PURA (PURA) Highlights ALKM Cannabis Co Packing Plans For $2 Trillion Market Opportunity
Rarely has any two industries been as compatible as the cryptocurrency and CBD industries. The projected market values for both industries are projected to get higher in the future.
Marco Alfonsi, Can B’s Chief Executive Officer, commented, “Our focused efforts on reducing costs has led to a significant reduction in operating losses. Additionally, when backing out non-cash expenses, our adjusted operating loss decreased by 37% to just over $200,000 for the quarter, largely attributable to the lay-offs due to COVID-19 circumstances.